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Background: The cause of idiopathic pulmonary fibrosis (IPF) remains unknown, yet gastro-esophageal reflux
disease (GERD) is highly prevalent in this population. GERD prevalence was studied, and esophageal function tests
(EFT) were assessed in Chinese IPF patients.
Methods: We prospectively studied 69 IPF patients who undertook both stationary High Resolution esophageal
Manometry/Impedance (HRiM) and 24-hour esophageal Multi-Channel Intraluminal Impedance with pH Recordings
(MII/pH). Patients were divided into GERD+ and GERD- groups according to pH results. Controls were HRiM treated
healthy volunteers, and patients without IPF received HRiM and MII/pH diagnosed with GERD.
Results: 69 IPF patients, 62 healthy volunteers, and 88 IPF negative GERD patients were selected. GERD prevalence
in IPF was 43/69 (62.3%), and 58.1% of patients presented with at least one typical symptom. Symptoms had a
sensitivity of 58.1%, a specificity of 61.6%, a positive predictive value of 71.4% and a negative predictive of 47.1%.
Compared with healthy volunteers, IPF patients had significantly decreased lower esophageal sphincter pressure
(LESP), upper esophageal sphincter pressure (UESP) and complete bolus transit rate (CBTR). By contrast, IPF patients
had increased total bolus transit time and prevalence of weak peristalsis. MII/pH showed that one third of IPF
patients had abnormal distal and proximal reflux, especially non-acid reflux. Compared with GERD patients without
IPF, GERD patients with IPF had significantly decreased CBTR and UESP with increased bolus exposure time.
Conclusions: GERD prevalence in IPF was high, but symptoms alone were an unreliable predictor of reflux. IPF
patients had lower LESP and UESP, impaired esophageal peristalsis and bolus clearance function with more
proximal reflux events.
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Idiopathic pulmonary fibrosis (IPF) is a chronic and pro-
gressive fibrotic lung disease that is characterized by a
histological pattern of interstitial pneumonia with a median
survival from the time of diagnosis of 2 – 3 years [1-3]. Al-
though the cause of IPF is unknown, gastro-esophageal re-
flux disease (GERD) is highly prevalent in this population
[4-6], and emerging data supports a role for chronic
micro-aspiration (e.g., subclinical aspiration of small* Correspondence: shangmed@163.com
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unless otherwise stated.droplets of refluxate), which may cause repetitive subclin-
ical injury to the lung leading to pulmonary fibrosis [3,7].
The last ten years has been an exciting time in the
study of esophageal motor disorders due in part to ad-
vances in esophageal function testing methodology.
Techniques like manometry have enjoyed many im-
provements due to advances in transducer technology,
computerized automation, advances in software devel-
opment, and topographic color-plot data presentation
[8-10]. In addition, the concomitant measurement of
esophageal intraluminal impedance, which provides
complementary data that details functional bolus transit
during manometry without the need for radiation, hasis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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(EFT).
Using these techniques, we studied the prevalence of
GERD and esophageal motility disorders in Chinese pa-
tients presenting with idiopathic pulmonary fibrosis




The study received ethics approval from the local Ethics
Board of Beijing Chao-Yang Hospital, and the Capital
Medical University, China. In addition, all participants
gave written informed consent.
Patient selection
This was a retrospective study that evaluated all patients
who undertook stationary High Resolution esophageal
Manometry/Impedance (HRiM), and 24-hour esophageal
Multi-Channel Intraluminal Impedance with pH (MII/
pH) recordings at the Digestive Department of Beijing
Chao-Yang Hospital, Capital Medical University from
July 2011 - July 2013. Chinese patients that presented
with IPF were included in this study and treated at the
respiratory Department of Beijing Chao-Yang Hospital,
Capital Medical University. GERD patients without IPF
were included as a control group. Patients with other
chronic active medical diseases (e.g., patients that pre-
sented with coronary artery disease, hypertension, malig-
nancy, diabetes mellitus, and connective tissue disease)
were excluded. Normal HRiM values were taken from
healthy volunteers at the Digestive Department of Beijing
Chao-Yang Hospital, Capital Medical University from
January 2010 - January 2011.
Each patient had an established diagnosis that was
confirmed by a pulmonary medicine physician. The diag-
nosis of IPF met the American Thoracic Society (ATS)
and European Respiratory Society (ERS) criteria for the
diagnosis of IPF, which required the absence of an iden-
tifiable etiology for interstitial lung disease and a histo-
pathological or radiological usual pattern of interstitial
pneumonia [1,2].Data collection
Values of forced vital capacity (FVC) and diffusing cap-
acity of the lung for carbon monoxide (DLCO) from
pulmonary function tests were collected and analyzed.
All patients answered a validated questionnaire with typ-
ical symptoms were defined as heartburn, regurgitation,
chest pain and atypical symptoms such as cough, dys-
pnea on exertion, belch, difficulty swallowing, globus
sensation, hoarseness and epigastric pain. Current use of
acid reducing medications was also documented.Stationary high resolution esophageal manometry
and impedance
A specially designed solid-state manometry catheter
(Sandhill Scientific Inc., Highland Ranch, CO, USA) that
was equipped with 32 manometric sensors and four
pairs of MII sensors separated by a 5 cm interval, was
used to determine esophageal pressures and impedance
in patients that were examined in the supine position.
The lower esophageal sphincter (LES) was examined
with distal circumferential manometric sensors. The
catheter was positioned so that the pressure transducers
were located across the upper esophageal sphincter,
esophageal body, and the LES; in addition the distal
channels were positioned in the stomach. Ten oral ad-
ministrations of 5 ml normal (0.9%) saline solution were
then performed at 30-second intervals, followed by 10
additional swallows of a synthetic gel of known viscosity
(EFT Viscous, Sandhill Scientific Inc., #500 Highland
Ranch, CO, USA).
Measurements of esophageal physiology were stan-
dardized in recent years so that acquired data is compar-
able across sites and between research studies. The
standardized protocol (adopting the Chicago Classifica-
tion) requires that each patient orally ingests 10 × 5 ml
liquid boli (at a rate of approximately one swallow per
minute) in order to assess the parameters of normal
peristalsis. Saline is used (as opposed to regular drinking
water) as it increases the signal detected by electric im-
pedance electrodes that track bolus transit. As liquid is
relatively uncomplicated to clear for most people, an
additional ‘peristaltic challenge’ is often used by swallow-
ing a viscous gel, which better resembles normal food.
This can often reveal abnormalities in peristalsis that is
not seen with liquid.
Esophageal bolus clearance can be assessed by meas-
urement of total bolus transit time (TBTT) by classifying
swallows as a complete bolus transit (i.e., if the bolus
entry occurs at the most proximal site, and bolus exit
points are recorded in all three distal recording seg-
ments) or as incomplete bolus transit (i.e., if the bolus
exit is not identified at any of the three distal recording
segments), and complete bolus transit rate (CBTR) [11].
The distal contractile integral (DCI) of the distal seg-
mental contraction is a parameter that integrates the
length of the smooth muscle esophagus (cm), contractile
pressure (mm Hg), and duration (s) of contraction. Dis-
tal esophageal amplitude (DEA) is an average of the con-
traction amplitude at 5 and 10 cm above the LES.
Integrated relaxation pressure (IRP) reports mean EGJ
pressure that is measured with an electronic equivalent
of a sleeve sensor in four continuous or non-continuous
seconds of relaxation in the ten-second window after de-
glutitive LES relaxation. The normal range for isobaric
contour breaks was 0–20% for >5 cm breaks (“large
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Patients were classified as “normal peristalsis” if they
had presented with a number of peristaltic breaks within
the normal range or had no peristaltic breaks. Patients
were classified with “weak peristalsis” if they had pre-
sented with 20-100% large breaks or 30-100% small
breaks of peristalsis [8,12,13].
24-hour oesophageal multi-channel intraluminal
impedance and pH recordings
The 2.1 mm outer diameter study catheter was com-
prised of six electrode pairs measuring the intraluminal
impedance at 3, 5, 7, 9, 15, and 17 cm above the LES,
and an antimony pH sensor that was 5 cm above the
LES (Sandhill Scientific Inc., Highland Ranch, CO,
USA). An impedance amplifier, delivered an ultra-low
current over a range of 1–2 KHz with resulting current
flow variations in response to changes in intraluminal im-
pedance (i.e., high impedance indicates gas or air, low im-
pedance indicates liquid). The signals from six impedance
channels and one pH channel were recorded at 50 sam-
ples per second. The data were stored in an ambulatory
recorder and saved on a 256 MB Compact Flash card. The
study was performed as an outpatient design after an over-
night fast with LES that was located by esophageal man-
ometry. All patients were at least 7 days off PPI therapy
and H2 receptor antagonist treatment, and 3 days off β re-
ceptor agonist, aminophylline and nitrate therapy.
Acid reflux events were defined as the point at which
the distal pH dropped to below pH 4 (acid). Non-acid
reflux events were detected as retrograde reductions in
the impedance signal representing liquid reflux events
with a pH > 4. Acid exposure time (%) was defined as
the total time at pH < 4 divided by the time monitored.
Liquid bolus entry was the time at which a 50% fall in
impedance from the baseline defining the liquid reflux
was reached. Bolus duration was the time between liquid
bolus entries to the time of liquid bolus clearance, which
was defined as the moment when impedance increased
to values denoting liquid reflux entry for ≥ 5 s. Bolus
duration was measured at the impedance site at a height
of 5 cm above the LES. Bolus exposure time (%) was de-
fined as the bolus duration time divided by the time
monitored [10]. Distal reflux events were measured by
the impedance site that was located 5 cm above the LES,
and proximal reflux events were measured by the im-
pedance site that was located 15 cm above the LES.
Comparison groups
IPF Patients were divided into GERD+ and GERD- groups
according to the results of the 24-hour pH monitoring
process [10]. Abnormal upright (≥6.3%) or recumbent
(≥1.2%) or total (≥4.2%) acid exposure time and/or a
Demeester score greater than 14.7 [14]. Values of HRiMbetween those found for IPF patients and those found for
healthy volunteers were compared, and values of HRiM
and MII/pH between GERD patients and those without
IPF were also compared.
Statistical methods
Categorical data were described as singular data points,
and continuous data as mean ± SD. Data were analyzed
by one-sample Student’s t test, independent sampled t
test or Chi-square test. A p value <0.05 was considered
as statistically significant. All data were analyzed with
SPSS 17.0 software analysis tool.
Results
Between July 2011 and July 2013, 346 patients undertook
HRiM and MII/pH therapy, and 88 of the patients were
treated with IPF. In addition, 19 of them also presented
with coronary artery disease, diabetes and connective tis-
sue diseases, and 69 patients that presented with IPF
were enrolled to the study. Between January 2010 and
January 2011, 62 healthy volunteers were enrolled to the
study in our department to measure the normal values
of HRiM in the population of northern China, and these
patients were enrolled as a control group of HRiM
treated subjects. After analyzing the results of all 346 pa-
tients, 88 patients without coronary artery disease, dia-
betes, lung diseases and connective tissue diseases, were
diagnosed with GERD and were then subsequently en-
rolled as a positive control group of GERD patients.
The demographic data and symptoms of patients with
IPF are shown in Table 1. Also, 43 patients were in the
GERD+ group and 26 patients were in GERD- group.
There were no significant differences in terms of age,
gender, former smoking behavior, duration of disease,
FVC, or DLCO (P > 0.05). Both groups of patients also
presented with similar symptoms.
The results of HRiM between patients with IPF and
healthy volunteers are shown in Table 2. Compared with
healthy volunteers, patients with IPF showed a pattern of
a significantly older age, significantly lower LESP, UESP,
DCI, DEA, and CBTR, while they also showed signifi-
cantly higher TBTT and prevalence of weak peristalsis.
Abnormal proximal reflux events were observed in
37.7% (26/69) patients with IPF, and abnormal distal re-
flux events were observed in 33.3% (23/69) of patients
(Table 3). However, a common abnormality was non-
acid reflux, and thus 71% of patients had a negative
DeMeester score. Comparisons of GERD patients with
and without IPF are shown in Table 4. GERD patients
with IPF showed significantly lower UESP, significantly
lower CBTR, and significantly higher bolus exposure
times. By contrast, GERD patients with IPF showed no
statistical difference of LESP, weak peristalsis, acid ex-
posure time, distal and proximal reflux events.





Sensitivity Specificity % PPV NPV % Independent-Sample
t test or Chi-square
Age (mean ± SD, yr) 57.9 ± 10.3 62.5 ± 10.1 - - P = 0.077
Male/ Female, n (% ) 19/24 12/14 - - P = 0.873
Former smoker , n 21 10 - - P = 0.431
FVC (%, mean ± SD) 65.3 ± 6.4 64.2 ± 7.1 - - P = 0.557
DlCO (%, mean ± SD) 51.6 ± 9.1 48.8 ± 7.5 - - P = 0.194
Duration of disease (mean ± SD, month) 22.8 ± 23.2 16.4 ± 18.3 - - P = 0.231
Heartburn, n (%) 25(58.1) 9(34.6) 58.1 73.5 P = 0.058
65.4 48.6
Chest Pain, n (%) 3(6.9) 1(3.8) 6.9 75.0 P = 0.168
96.2 38.5
Regurgitation, n (%) 1(2.3) 1(3.8) 2.3 50.0 P = 0.715
96.2 37.3
Any typical symptom 25(58.1) 10(38.4) 58.1 71.4 P = 0.113
61.6 47.1
Cough, n (%) 40(93.0) 25(96.1) 93.0 61.5 P = 0.590
3.9 25.0
Dyspnea on exertion, n (%) 38(88.0) 22(84.6) 88.4 63.3 P = 0.653
15.4 44.4
Belch, n (%) 6(13.9) 1(3.8) 13.9 85.7 P = 0.178
96.2 40.3
Difficulty swallowing, n (%) 1(2.3) 0(0) 2.3 100 P = 0.433
100 38.2
Epigastric pain, n (%) 2(4.6) 0(0) 4.6 100 P = 0.264
100 38.8
GERD: gastro-esophageal reflux disease; FVC: forced vital capacity; DLCO: diffusing capacity of the lung for carbon monoxide; PPV: positive predictive value;
NPV: negative predictive value.
Gao et al. BMC Gastroenterology  (2015) 15:26 Page 4 of 8Discussion
The last ten years has seen considerable advances in the
sensitivity of techniques to study esophageal motor dis-
orders and GERD, which have collectively revealed clin-
ical features that can help explore the pathophysiology
of various conditions in great detail [9,10]. Impedance
monitoring is a new method that allows detection of
bolus transit. It does so by detecting a change in the re-
sistance to current flow between pairs of electrodes
when a liquid and/or gas bolus bridges them. When a li-
quid bolus bridges the two electrode rings, impedance
decreases directly with the degree of bolus ionization. By
contrast, a gas bolus increases impedance. These differ-
ences in impedance characteristic allows the differenti-
ation of liquid, gas and combined liquid–gas (mixed)
boluses. In addition, combining impedance with pH
monitoring can determine bolus exposure time, compos-
ition, and proximal extent of the refluxate. Both of these
measures can be used to assess the risk for micro-
aspiration [7].In this study, we found that the prevalence of GERD
in Chinese patients with IPF was high (i.e., 62.3%), but
GERD symptoms were found to be a poor predictor of
the presence of reflux within the group. The sensitivity
and specificity of any typical symptoms (e.g., heartburn,
regurgitation and chest pain) was 58.1% and 61.6%, posi-
tive predictive value, and the negative predictive value
was 71.4% and 47.1%. These data confirm that Chinese
patients with IPF have a similar profile as those seen in
other countries in previous studies [4,15-17]. The rela-
tively poor sensitivity and specificity of using symptoms
alone outlines the importance of performing objective
assessments of esophageal function and reflux status in
IPF as opposed to empirically treating GERD in the
entire cohort.
Although the cause of IPF remains unknown, several
associations have been described, including cigarette
smoking, exposure to wood and metal dusts, chronic
viral infection, exposure to some drugs (e.g., antidepres-
sants) and hereditary factors and mutations in the genes
Table 2 Results of high-resolution manometry and
impedance




Chi-square testn = 69 n = 62
Mean ± SD Mean ± SD
Age 57.9 ± 10.3 32.0 ± 11.3 P < 0.001
Gender (M/F) 31/38 25/37 P = 0.595
LESP mm Hg 17.4 ± 8.8 26.3 ± 10.8 P < 0.001
Hypotensive
LES n (%)
13 2 P = 0.005
LESRP mm Hg 4.0 ± 5.0 6.6 ± 4.7 P = 0.008
IRP mm Hg 8.1 ± 4.6 10.4 ± 4.9 P = 0.008
UESP mm Hg 77.7 ± 39.2 101.4 ± 49.5 P < 0.001
DEA mm Hg 59.3 ± 37.0 95.3 ± 35.4 P < 0.001
DCI mm Hg.cm.s 754.1 ± 720.9 1891 ± 1131 P < 0.001
Hiatal hernia n (%) 7 (10.1) 1 (1.6) P = 0.046
Peristalsis n (%)
Normal 37 (53.6) 57 (91.9) P < 0.001
Weak 32 (46.4) 5 (8.1)
TBTT s 7.5 ± 1.4 6.9 ± 0.9 P = 0.016
CBTR % 78.0 ± 20.5 90.3 ± 14.0 P < 0.001
Key:
IPF: idiopathic pulmonary fibrosis; LESP: lower esophageal sphincter pressure;
LES: lower esophageal sphincter; LESRP: lower esophageal sphincter residual
pressure; IRP: integrated relaxation pressure. UESP: upper esophageal sphincter
pressure; DCI: distal contractile integral; DEA: distal esophageal amplitude;
TBTT: total bolus transmit time; CBTR: complete bolus transit rate.
Table 3 24-hour multi-channel intraluminal impedance
and pH measurements
Measurements n = 69 N (%)
Abnormal acid exposure time 43 (62.3)
Upright ≥6.2% 18 (26.0)
Recumbent ≥1.2% 28 (40.6)
Total ≥4.2% 20 (29.0)
Total proximal reflux events: acid 714 (50.7)
Non-acid 695 (49.3)
Patients with abnormal proximal reflux events 26 (37.7)
Acid reflux event ≥28 5 (7.2)
Non-acid reflux event ≥13 22 (31.9)
Total reflux event ≥31 15 (21.7)
Total distal reflux: acid 1187 (43.8)
Non-acid 1524 (56.2)
Patients with abnormal distal reflux events 23 (33.3)
Acid reflux event ≥55 0 (0)
Non-acid reflux event ≥27 23 (33.3)
Total reflux event ≥73 5 (7.2)
DeMeester score: positive 20 (29.0)
Negative 49 (71.0)
Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a
multi-center report of normal values from 60 healthy volunteers [10].
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ging data supports a role for chronic micro-aspiration
(e.g., subclinical aspiration of small droplets due to
GERD) which may cause repetitive subclinical injury to
the lung leading to pulmonary fibrosis [3,7]. Studies
[19,20] have been described that show IPF patients that
presented with increased prevalence of hiatal hernia and
IPF patients that presented with hiatal hernia had a
greater physiological impairment on pulmonary function
testing. Mays et al. [21] suggested that repeated small
tracheobronchial aspiration of gastric secretions over a
long period of time could lead to lung fibrosis. Lee et al.
[22] detected pepsin, a biomarker of micro-aspiration, in
bronchial alveolar lavage (BAL) fluid from patients with
IPF, and it was direct evidence that showed that gastric
contents can reach the lower respiratory tract without
an overt aspiration. The observed association of hiatal
hernia and abnormal GERD coupled with the detection
of pepsin in BAL specimens retrieved from the distal
pulmonary parenchyma supports the long-standing hy-
pothesis that micro-aspiration is a causative role in the
development of IPF and may trigger episodes of acute
execrations of IPF.For several decades, esophageal specialists have postu-
lated that altered respiratory mechanics in patients with
end-stage lung disease may cause reflux. Specifically, in-
creases in positive intra-abdominal pressure and negative
intrathoracic pressure (with a corresponding increase in
the transdiaphragmatic pressure gradient) could cause a
gradient-favoring reflux [23,24]. Survival analysis [25]
showed that identifying the presence of gastro-esophageal
symptoms, providing a reflux diagnosis, medication use,
and Nissen fundoplication were all collectively associated
with longer survival in IPF.
In this study, we also found that patients with IPF pre-
sented with lower LESP and UESP, higher prevalence of
hypotensive LESP and hiatal hernia, and combined im-
pedance showed that in addition to 46.4% of patients
having weak peristalsis, 33.3% of patients had abnormal
distal reflux events, 37.7% of patients had abnormal
proximal reflux events, and moreover, IPF patients pre-
sented with higher TBTT and lower CBTR which meant
that the bolus transit was impaired.
The esophagus comprises striated muscle in the prox-
imal third of the esophageal body and smooth muscle in
the distal two-thirds. Where these two types of muscle
meet there is a ‘transition zone’ which can lead to a
‘break’ in the peristaltic wave as it travels distally. This
occurs in healthy individuals under normal conditions,
but it has been shown that if this break is greater than
Table 4 Comparisons of GERD patients with versus







N = 43 N = 88
Age 57.9 ± 10.2 54.2 ± 12.3 P = 0.097
Gender 19/24 39/49 P = 0.989
LESP (mean ± SD) 16.7 ± 9.4 16.3 ± 11.7 P = 0.811
LESRP (mean ± SD) 4.0 ± 5.0 4.8 ± 4.5 P = 0.372
IRP (mean ± SD) 8.2 ± 5.1 7.9 ± 5.6 P = 0.717
UESP (mean ± SD) 66.3 ± 16.5 78.0 ± 29.6 P = 0.018
DEA (mean ± SD) 59.3 ± 37.0 61.6 ± 31.3 P = 0.713
DCI (mean ± SD) 792.2 ± 838.3 592.4 ± 746.4 P = 0.169
Peristalsis n (%)
Normal 24 (55.8) 53 (60.2) P = 0.630
Weak 19 (44.1) 35 (39.8)
TBTT s 7.4 ± 1.6 7.0 ± 1.3 P = 0.115
CBTR % 56.0 ± 37.0 69.4 ± 34.0 P < 0.001
Acid exposure (pH) Percent time (%)
Upright 6.4 ± 8.2 5.4 ± 5.7 P = 0.405
Recumbent 4.3 ± 5.9 2.6 ± 4.2 P = 0.099
Total 4.8 ± 4.2 4.2 ± 3.8 P = 0.403
DeMeester score 15.9 ± 12.6 15.0 ± 12.8 P = 0.713
Bolus exposure All reflux time (%)
Upright 4.6 ± 3.4 3.0 ± 2.5 P = 0.008
Recumbent 1.5 ± 2.1 0.6 ± 1.3 P = 0.022
Total 2.8 ± 2.0 1.9 ± 1.7 P < 0.009
Reflux Episodes Activity
Distal Acid 21.1 ± 11.3 21.3 ± 14.8 P = 0.927
Reflux Nonacid 24.3 ± 14.8 20.1 ± 14.5 P = 0.199
n Total 45.5 ± 17.9 41.4 ± 23.7 P = 0.326
Proximal Acid 13.0 ± 9.2 12.1 ± 10.1 P = 0.523
Reflux Nonacid 11.0 ± 8.5 11.1 ± 10.6 P = 0.615
n Total 24.3 ± 14.8 23.1 ± 17.3 P = 0.951
GERD: gastro-esophageal reflux disease; IPF: idiopathic pulmonary fibrosis;
LESP: lower esophageal sphincter pressure; LESRP: lower esophageal sphincter
residual pressure; IRP: integrated relaxation pressure. UESP: upper esophageal
sphincter pressure; DCI: distal contractile integral; DEA: distal esophageal
amplitude; TBTT: total bolus transmit time; CBTR: complete bolus transit rate.
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transported and cleared into the stomach. In patients
with weak peristalsis, these breaks can often be charac-
terized as small (2–5 cm) or large (>5 cm). It has been
demonstrated that among healthy volunteers weak peri-
stalsis of the esophageal body has predicted incomplete
bolus clearance [26] and might account for delayed
bolus transit and impaired esophageal reflux clearance in
patients with GERD [27,28]. In addition, weak peristalsiswith large breaks is associated with high acid exposure
and delayed reflux clearance in the supine position in
GERD patients [28]. Moreover, GERD patients with IPF,
have presented with lower UESP, lower CBTR and a
higher bolus exposure time than GERD patients without
IPF. This means that there is an increasing possibility of
small droplets from the esophagus that are capable of
being aspirated into the trachea, and supports the hy-
pothesis that GERD and chronic micro-aspiration may
play a major role in the pathobiology of IPF.
GERD has long been known to be an important cause of
chronic cough. Indeed a diagnosis of gastro-esophageal
acid reflux-associated cough (GERC) is often made follow-
ing a successful, empirical trial of high-dose acid suppres-
sion therapy. Thus, a particular attraction of the reflux
hypothesis is that it could explain both the pathogenesis of
IPF and the associated symptom of cough. However, the
lack of improved cough symptoms despite effective acid
suppression therapy indicates that gastroesophageal acid
reflux alone is not wholly responsible for cough in the ma-
jority of patients with IPF. A recent advance in the assess-
ment of non-acid reflux is the technique of combined
esophageal pH and impedance monitoring, which pro-
vides a means of detecting acid and non-acid reflux. Savar-
ino et al. [29] reported a high frequency of occurrence of
acid reflux events, non-acid reflux events, and reflux
reaching the proximal esophagus in patients with systemic
sclerosis and interstitial lung disease. Our study also found
that patients with IPF had more distal and proximal reflux
events, especially non-acid reflux, which showed com-
bined impedance and pH recordings that provided a more
accurate assessment of the specific pattern of reflux.
Mise et al. [30] reported lower DLCO in patients with
recently diagnosed GERD in comparison with healthy
controls. Bonacin et al. [31] showed statistically signifi-
cant increases in FVC in the GERD group as compared
with the non-GERD group. Among the GERD group,
values of DLCO and DLCO/VA were significantly lower,
and intrapulmonary shunt was significantly higher in
comparison with the non-GERD group, which confirmed
the correlation between GERD and damaged lung func-
tion. The results of that study suggested an additional
pathological mechanism in the development of intrapul-
monary shunt, due in part, to microatelectasis resulting
from surfactant damage caused by micro-aspiration of
the stomach contents. Both of the aforementioned stud-
ies stated the need for early lung function tests in all
GERD patients. In our study, esophageal function pa-
rameters in IPF patients presenting with GERD did not
correlate with worsened pulmonary function (FVC or
DLCO). We also did not find a significant correlation in
our research between FVC or DLCO and motility or re-
flux. This may be due to the relatively small numbers of
research subjects that were recruited to this study (i.e.,
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was not powered to detect these changes), and the inclu-
sion of IPF patients at the milder end of the spectrum.
Some researchers [32-34] have showed that anti-reflux
surgery can improve lung function of GERD patients so
further studies are required to determine whether anti-
reflux surgery or using PPI might improve the prognosis
of IPF patients.
Our study also has some limitations. All subjects
were recruited from one hospital and in only one city,
which might have a potential selection bias. Besides,
the small number of patients limited the statistical
power of the study. The life signs of all 346 patients
were stable but in some of the severe presenting pa-
tients who needed inspired oxygen management, we
decided that they should not undertake the procedure.
Whilst this means there is somewhat the risk of a se-
lection bias for patients at the mild end of the IPF
spectrum, we felt justified to use these inclusion cri-
teria on the grounds of patient safety and to exclude
the confounders of other underlying diseases (e.g., con-
nective tissue disease) to esophageal motility. Healthy
Chinese volunteers were younger than IPF patients,
and we used the diagnostic criteria of abnormal acid
exposure from the USA. However, we do have suffi-
cient merit to demonstrate that it is important to
screen GERD in IPF patients, even if there do not
present with typical reflux symptoms.
Conclusions
GERD prevalence in Chinese patients with IPF was high,
whereas GERD symptoms were a poor predictor of
GERD being present. IPF patients had lower LESP and
UESP, impaired esophageal peristalsis and bolus clear-
ance function, and a higher frequency of proximal reflux
events. Combined MII/pH should be considered the
‘gold standard’ in assessing reflux in IPF.
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